Practical Functional Evaluation of Adrenal Mass

  • Francesco Porpiglia
  • Riccardo Autorino
  • Cristian Fiori


Over the past few decades the widespread application of non-invasive, high resolution imaging techniques such as MRI and CT has led to the incidental discovery of asymptomatic adrenal masses with increasing frequency. These masses, named “adrenal incidentalomas” (AIs), raise challenging questions for physicians and their patients. The diagnostic approach has to be focused on distinguishing benign and non-secreting from malignant or hormone secreting adrenal masses, and this approach combines radiological and functional evaluations. The aim of this chapter is to review the main techniques for the functional evaluation of AIs.


Adrenal mass Adrenal incidentaloma Assessment Diagnostic test 


Acknowledgments and Conflict of Interest



  1. 1.
    Anagnostis P, Karagiannis A, Tziomalos K, Kakafika AI, Athyros VG, Mikhailidis DP. Adrenal incidentaloma: a diagnostic challenge. Hormones (Athens). 2009;8(3):163–84.CrossRefGoogle Scholar
  2. 2.
    Aron D, Terzolo M, Cawood TJ. Adrenal incidentalomas. Best Pract Res Clin Endocrinol Metab. 2012;26(1):69–82.CrossRefPubMedGoogle Scholar
  3. 3.
    Barzon L, Boscaro M. Diagnosis and management of adrenal incidentalomas. J Urol. 2000;163(2):398–407.CrossRefPubMedGoogle Scholar
  4. 4.
    Funder JW, Carey RM, Fardella C, Gomez-Sanchez CE, Mantero F, Stowasser M, Young WF, Montori VM. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metabol. 2008;93(9):3266–81.CrossRefGoogle Scholar
  5. 5.
    Italian Society of Urology (S.I.U.). Guidelines on adrenal incidentaloma. 2011.Google Scholar
  6. 6.
    Pacak K, Eisenhofer G, Ahlman H, Bornstein SR, Gimenez-Roqueplo AP, Grossman AB, Kimura N, Mannelli M, McNicol AM, Tischler AS. Pheochromocytoma: recommendations for clinical practice from the First International Symposium. Nat Clin Pract Endocrinol Metab. 2007;3(2):92–102.CrossRefPubMedGoogle Scholar
  7. 7.
    Porpiglia F, Fiori C, Daffara F, Zaggia B, Bollito E, Volante M, Berruti A, Terzolo M. Retrospective evaluation of the outcome of open versus laparoscopic adrenalectomy for stage I and II adrenocortical cancer. Eur Urol. 2010;57(5):873–8.CrossRefPubMedGoogle Scholar
  8. 8.
    Terzolo M, Stigliano A, Chiodini I, Loli P, Furlani L, Arnaldi G, Reimondo G, Pia A, Toscano V, Zini M, Borretta G, Papini E, Garofalo P, Allolio B, Dupas B, Mantero F, Tabarin A. AME position statement on adrenal incidentaloma. Eur J Endocrinol. 2011;164(6):851–70.CrossRefPubMedGoogle Scholar
  9. 9.
    Terzolo M, Bovio S, Pia A, Reimondo G, Angeli A. Management of adrenal incidentaloma. Best Pract Res Clin Endocrinol Metab. 2009;23(2):233–43.CrossRefPubMedGoogle Scholar
  10. 10.
    Ridho FE, Adam FM, Adam JM. Adrenal incidentaloma. Acta Med Indones. 2009;41(2):87–93.PubMedGoogle Scholar
  11. 11.
    Zini L, Porpiglia F, Fassnacht M. Contemporary management of adrenocortical carcinoma. Eur Urol. 2011;60(5):1055–65.CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag London 2017

Authors and Affiliations

  • Francesco Porpiglia
    • 1
  • Riccardo Autorino
    • 2
  • Cristian Fiori
    • 1
  1. 1.Division of Urology, Department of OncologySchool of Medicine, University of Turin, “San Luigi Gonzaga” HospitalOrbassano (Torino)Italy
  2. 2.University Hospitals Urology Institute, Case Western UniversityClevelandUSA

Personalised recommendations